Andrea Belanger
Director, Precision Diagnostics Partnering GlaxoSmithKline
Seminars
Tuesday 23rd September 2025
Panel Discussion: Assessing Biopharma Partnership Selection Strategies in Precision Medicine to Strengthen Strategic Partnerships & Accelerate Clinical Success
11:10 am
- What capabilities, compliance, or market experience drive appetite to collaborate with a particular partner? And how do different pharma companies prioritize partner selection considering these criteria?
- What is the significance of global partner footprint in the context of co-development and large-scale manufacturing?
